Growth Metrics

Tandem Diabetes Care (TNDM) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$1.3 billion.

  • Tandem Diabetes Care's Retained Earnings fell 1939.44% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 1939.44%. This contributed to the annual value of -$1.0 billion for FY2024, which is 1008.88% down from last year.
  • Latest data reveals that Tandem Diabetes Care reported Retained Earnings of -$1.3 billion as of Q3 2025, which was down 1939.44% from -$1.2 billion recorded in Q2 2025.
  • Tandem Diabetes Care's Retained Earnings' 5-year high stood at -$634.6 million during Q4 2021, with a 5-year trough of -$1.3 billion in Q3 2025.
  • Over the past 5 years, Tandem Diabetes Care's median Retained Earnings value was -$888.8 million (recorded in 2023), while the average stood at -$880.8 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Retained Earnings skyrocketed by 455.58% in 2021 and then plummeted by 3378.72% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Retained Earnings (Quarter) stood at -$634.6 million in 2021, then dropped by 14.91% to -$729.2 million in 2022, then tumbled by 30.53% to -$951.8 million in 2023, then dropped by 10.09% to -$1.0 billion in 2024, then decreased by 19.48% to -$1.3 billion in 2025.
  • Its last three reported values are -$1.3 billion in Q3 2025, -$1.2 billion for Q2 2025, and -$1.2 billion during Q1 2025.